SCHEMBL1362839

SCHEMBL1362839

O=C(O)/C=C/C=C/CCC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 1/20 0.52
▸ KDM4E B2RXH2 1/20 0.44
▸ FASN P49327 1/20 0.44
▸ OXER1 Q8TDS5 3/20 0.43
▸ MAPT P10636 2/20 0.43
▸ FFAR1 O14842 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ CYP19A1 P11511 1/20 0.43
▸ RXRA P19793 1/20 0.43
▸ PPARG P37231 1/20 0.43
▸ TBXAS1 P24557 2/20 0.40
▸ ALOX12 P18054 3/20 0.38
▸ ACHE P22303 1/20 0.37
▸ BACE1 P56817 1/20 0.37
▸ TSHR P16473 3/20 0.37
▸ GABRR1 P24046 2/20 0.37
▸ GABRR2 P28476 2/20 0.37
▸ BLM P54132 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ GABRR3 A8MPY1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1362840 1.00 PPARA (0.52) PPARAKDM4EFASNOXER1MAPT
SCHEMBL2547406 0.98 PPARA (0.50) PPARAKDM4EFASNOXER1MAPT
SCHEMBL2547407 0.98 PPARA (0.50) PPARAKDM4EFASNOXER1MAPT
SCHEMBL11580318 0.87 ALDH1A1 (0.52) KDM4EFASNOXER1MAPTFFAR1
SCHEMBL11580321 0.87 ALDH1A1 (0.52) KDM4EFASNOXER1MAPTFFAR1
SCHEMBL27075769 0.86 FASN (0.55) PPARAKDM4EFASNOXER1MAPT
SCHEMBL3504734 0.85 PPARA (0.65) PPARAPPARGTBXAS1ACHEBACE1
SCHEMBL3504730 0.85 PPARA (0.65) PPARAPPARGTBXAS1ACHEBACE1
SCHEMBL2551150 0.85 FASN (0.63) PPARAKDM4EFASNOXER1MAPT
SCHEMBL2551147 0.85 FASN (0.63) PPARAKDM4EFASNOXER1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101516861-B Method for producing bisbenzoxazoles CLARIANT INT LTD 2014-07-16 — — CN claimed
US-8067612-B2 Method for producing bisbenzoxazoles CLARIANT FINANCE (BVI) LIMITED (VG) 2011-11-29 — — US claimed
US-20100076040-A1 Method For Producing Bisbenzoxazoles Clariant Finance Wickhams Cay (VG) 2010-03-25 — — US claimed
CN-101516861-A Method for producing bisbenzoxazoles CLARIANT INT LTD (VG) 2009-08-26 — — CN claimed
EP-0662946-A1 UNSATURATED ALIPHATIC DICARBOXYLIC ACIDS UNICHEMA CHEMIE B.V. (NL) 1995-07-19 — — EP claimed
WO-1994007837-A1 UNSATURATED ALIPHATIC DICARBOXYLIC ACIDS UNICHEMA CHEMIE B.V. (NL) 1994-04-14 — — WO claimed
US-20240156701-A1 HAIR TREATMENT COMPOSITION AND HAIR TREATMENT METHOD DSTYLE HOLDINGS CO., LTD. (JP) 2024-05-16 — — US disclosed
EP-4316601-A1 HAIR TREATMENT COMPOSITION AND HAIR TREATMENT METHOD B. Pro Co., Ltd. (JP) 2024-02-07 — — EP disclosed
CN-113444164-B Solid-phase synthesis method of Somalutide 台州吉诺生物科技有限公司 2022-07-19 — — CN disclosed
CN-101516861-B Method for producing bisbenzoxazoles CLARIANT INT LTD 2014-07-16 — — CN disclosed
US-8067612-B2 Method for producing bisbenzoxazoles CLARIANT FINANCE (BVI) LIMITED (VG) 2011-11-29 — — US disclosed
US-20100076040-A1 Method For Producing Bisbenzoxazoles Clariant Finance Wickhams Cay (VG) 2010-03-25 — — US disclosed
CN-101516861-A Method for producing bisbenzoxazoles CLARIANT INT LTD (VG) 2009-08-26 — — CN disclosed
EP-0662946-A1 UNSATURATED ALIPHATIC DICARBOXYLIC ACIDS UNICHEMA CHEMIE B.V. (NL) 1995-07-19 — — EP disclosed
EP-0662946-A1 UNSATURATED ALIPHATIC DICARBOXYLIC ACIDS UNICHEMA CHEMIE B.V. (NL) 1995-07-19 — — EP disclosed
WO-1994007837-A1 UNSATURATED ALIPHATIC DICARBOXYLIC ACIDS UNICHEMA CHEMIE B.V. (NL) 1994-04-14 — — WO disclosed
WO-1994007837-A1 UNSATURATED ALIPHATIC DICARBOXYLIC ACIDS UNICHEMA CHEMIE B.V. (NL) 1994-04-14 — — WO disclosed
US-4014922-A CYCLOPROPYL SUBSTITUTED ESTERS; MITICIDES ZOECON CORPORATION (US) 1977-03-29 — — US disclosed
US-3983230-A HALF ESTERS WITH DICARBOXYLIC ACIDS, MEDICAMENTS SHIONOGI & CO., LTD. (JA) 1976-09-28 — — US disclosed
US-3948961-A CYCLOPROPYL ALKYL CARBOXYLATES, MITICIDE, INSECTICIDE ZOECON CORPORATION (US) 1976-04-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076040-A1 Method For Producing Bisbenzoxazoles DDO, DAO, AADAC PPARA 1070/4885KDM4E 914/4885FASN 807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback